Cannabis Growth ETF
BUDX
BUDX was delisted on the 25th of April, 2022.
0 hedge funds and large institutions have $0 invested in Cannabis Growth ETF in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $13K → $0 (-$13K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$11K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| – | -$11K | -956 | Closed |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| – | -$2K | -175 | Closed |
|
BUDX Hedge Fund Activity: Q2 2022 in Review
0 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Cannabis Growth ETF (BUDX) for Q2 2022, worth a combined $0 — down 100% from $13K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BUDX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $11K sold.
- 0 institutional investors held Cannabis Growth ETF (BUDX) as of Q2 2022, down from 2 in Q1 2022.
- Funds reported $0 of Cannabis Growth ETF stock for Q2 2022, down 100% quarter-over-quarter.
- 0 funds opened new Cannabis Growth ETF positions in Q2 2022 and 2 closed out, a net change of -2 holders.
- The largest Cannabis Growth ETF seller in Q2 2022 was UBS Group, an estimated $11K sold.
Based on aggregated 13F filings for Q2 2022.